+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07169708

Study of Nivolumab Plus Chemotherapy Before Surgery in Patients with Resectable Non-Small Cell Lung Cancer in Taiwan

Led by Ono Pharmaceutical Co., Ltd. · Updated on 2026-05-20

100

Participants Needed

9

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the real-world effectiveness and safety of Nivolumab combined with chemotherapy as neoadjuvant therapy for patients with resectable non-small cell lung cancer NSCLC in Taiwan. The study focuses on whether this combination leads to better pathological complete response pCR and event-free survival EFS in NSCLC patients. This observational study addresses gaps in current knowledge about treatment outcomes and patient profiles in the Taiwanese population following the recent approval of this regimen. Participants in this study have already received Nivolumab combined with chemotherapy as part of their regular medical care. Data will be collected retrospectively over at least 12 months, including treatment details, imaging assessments, surgical status, and pathological reports for those who underwent surgery. The study aims to gather information on treatment effectiveness, safety, and patient outcomes in a real-world setting without additional interventions. During the study, researchers will review medical records to measure the rate of pathological complete response, event-free survival, and occurrences of adverse events AE and serious adverse events SAE over at least 12 months. Participants must have been followed for at least 12 months or meet specific exceptions such as earlier death or disease progression. The study offers insight into how this treatment works in practice and monitors patient safety and outcomes over time.

CONDITIONS

Brief Title

A Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL)

Research Team

P

Penny Medical Affairs Specialist, Clinical Pharmacology

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here